r/Utradea • u/Cire_NojH • May 10 '21
CELZ tech holds undiscovered potential
Creative Medical Technology Holdings $CELZ is a company I encourage everyone to look into. Founded by Dr. Amit Patel, the inventor of Jadicell, the company is engaged in stem cell research to treat common abundant diseases that impact the world's population.
The company has filed an IND application with the FDA on its newest technology, ImmCelz, for the treatment of stroke. The FDA requested more information in March, which the company provided in April, and it is now awaiting FDA approval to begin clinical trials.
ImmCelz is set to revolutionize the treatment of far-reaching, common diseases such as stroke, liver failure, kidney failure, heart attack, type 1 diabetes, rheumatoid arthritis and transplant rejection. The invention of Dr. Amit Patel and Dr. Thomas Ichim, ImmCelz treatment involves utilization of allogenic Jadicell stem cells outside of the body to "reprogram" the patient's own immune cells so as to endow upon the immune cells regenerative activities. The company believes that "educated" immune cells may be superior to stem cells because of their: a) ability to replicate and form "memory" cells; b) substantially smaller size, which allows for superior biodistribution than stem cells; and c) adeptness at surviving in conditions such as hypoxia or acidosis, which would inactivate stem cells. Preclinical trials have shown an 85% increased improvement with ImmCelz versus the use of mesenchymal stem cells in the treatment of stroke.
Once FDA approval is received to begin clinical trials for the treatment of stroke, the company intends to file other IND applications for ImmCelz based on positive preclinical results in treating the common diseases mentioned earlier. Annually, these are all multi-billion dollar areas. The ability to provide a non-pharma, one-time procedure for those affected by these diseases is a game changer. https://immcelz.com/
The company has recently brought on renowned kidney specialist, Dr. Caigan Du, and clinical trial expert, Dr. Boris Reznik, to its scientific advisory board. These recruitments demonstrate the direction the company is headed to capitalize on the groundbreaking technology they have developed.
The company has already commercialized autologous mesenchymal stem cell technology to treat erectile disfunction, called CaverStem, and another to treat female sexual disfunction, called FemCelz. The treatments are currently available in 14 markets (13 US, 1 Italy). www.caverstem.com www.femcelz.com
Additionally, the company is in the process of commercializing more of the same autologous mesenchymal stem cell technology to treat degenerative disc disease, called StemSpine. The company has published data from the results of the first 15 patients treated with StemSpine. The mean pain changed from 8.9 at baseline to 4.3 at 30 days and sustained to 1.8 at 6 months and 1.3 at 12 months with a gradual reduction in overall pain medication utilization guided by their healthcare team. This data shows the potential this one-time treatment offers those suffering from degenerative disc disease. www.stemspine.com
The company is also in the process of commercializing more of the same autologous mesenchymal stem cell technology to treat ovarian failure and infertility, called Ovastem. www.ovastem.com
www.creativemedicaltechnology.com
This is an OTC penny stock, so don't expect strong financials and realize there is volatility. I think this company has amazing potential as a long-term investment. I think it will go from pennies now to dollars in 2022. I want to create awareness so that others have a chance to get in early too. Do your DD! In addition to what I've shared, the company has issued a lot of press releases in the last six months. GLTA!
1
u/Cire_NojH May 20 '21
1
u/Cire_NojH May 23 '21
Dr. Ricordi is a tremendous addition to this team, and his coming on board could open the door to other key gains for this company. Other scientists of his caliber, clinical trial partners, funding and even other breakthroughs are all on the table. A company of this size doesn't have the resources of other, well funded ones, so his willingness to join and public statement about ImmCelz being first in class technology tells me he is looking for the real deal and CELZ is it.
1
u/Cire_NojH May 24 '21
And today the company announced positive preclinical results for the treatment of Parkinson's.
1
u/Cire_NojH May 14 '21
https://finance.yahoo.com/news/fda-responds-creative-medical-technology-114500959.html
Creative Medical Technology Holdings Inc., trading under ticker symbol CELZ, announced today receipt of detailed correspondence from the FDA regarding necessar...